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ABSTrAcT
Daily contact with cats is an important risk factor for human campylobacteriosis. The main goal of this study was to 
investigate the virulence genes and antibiotic resistances of C. jejuni isolated from the stools of cats brought to Erciyes 
University, Faculty of Veterinary Medicine, Training and Research Hospital Clinics. In the study, feces taken from 
different breeds and ages (1 month to 9 years) of 200 (116 female, 84 male) cats were examined between May 2017 
and April 2018. Campylobacter spp. isolates were identified at genus and species level using genus specific multiplex 
PCR (mPCR), and the existence of iam, cadF, cdtA, flaA, ceuE, cdtC, cdtB and virB11 genes were found by PCR. 
The antimicrobial resistance and multidrug resitance (MDR) of the isolates were determined by disc diffusion test. 
By means of Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR), the genetic 
relativeness of the isolates were revealed. In this study, 41 (20.5%) of 200 stool samples were shown to be positive 
for Campylobacter spp. in the isolation of Campylobacter spp. from stool samples. In the positive samples, 14 of 22 
(63.6%) were from diarhoeic cats and 27 of 178 (15.1%) were non-diarhoeic cats. Also, in total 71 Campylobacter 
spp. suspicious isolates were recovered from the 41 positive samples obtained. Phenotypic tests and PCR revealed that 
65 isolates (20 from diarrhoeic and 45 from non-diarhoeic cat isolates) were identified as C. jejuni. The differences 
in isolation rate in relation to sex or age were not statistically significant (P>0.05). In terms of virulence genes, all 
C. jejuni isolates harbored at least five virulence genes. All isolates were positive for the cadF, cdtC and ceuE genes, 
respectively. C. jejuni isolates contained iam, cadF, cdtA, flaA, ceuE, cdtC, cdtB and virB11, at the rate of 19 (29.2%), 
65 (100%), 64 (98.4), 54 (83%), 65 (100%), 65 (100%), 64 (98.4%) and 22 (33.8%) respectively. Moreover, cdtA and 
cdtB toxin genes were found in most of the isolates analysed. All C. jejuni isolates were susceptible to amoxicillin 
clavulanic acid. The highest resistances of the isolates were found as follows; 64 (98.4%), 63 (96.9%), 62 (95.3%) 
for ciprofloxacin (CIP), trimethoprim sulfamethoxazole (SXT), nalidixic acid (NA) antibiotics, respectively. Multiple 
resistance of isolates was detected in the present study. Sixty-one (93.8%) out of 65 isolates were resistant to three 
or more antibiotics, and the highest resistance levels to three and seven antimicrobials were observed in 23.1% and 
15.3% of the isolates respectively. In the study, C. jejuni isolates were resistant to most antibiotics currently used, and 
had extraordinary virulence traits in cats which may constitute a non-negligible risk for public health. 
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Introduction
Campylobacter spp. is Gram negative, spiral, 
microaerophilic bacteria in the gastrointestinal tract 
in humans and animals (VANDAMME and DE 
LEY, 1991). The genus Campylobacter consists 
of 26 species and nine subtypes (KAAKOUSH 
et al., 2015; HEREDIA and GARCIA, 2018). 
In addition to cats and dogs, Campylobacter 
spp. is found as commensal in cattle, sheep, pigs 
and birds (HEREDIA and GARCIA, 2018). In 
humans, in addition to gastrointestinal disorders, 
Campylobacter spp. (especially C. jejuni and 
C. coli) can cause extra-intestinal findings, 
such as bacteremia, brain abscesses, meningitis, 
Guillain-Barre Syndrome and reactive arthritis 
(KAAKOUSH et al., 2015). Campylobacter spp. is 
also found in the gastrointestinal tracts of dogs and 
cats (BOJANIC et al., 2017). Daily contact with 
domestic cats is an important risk factor for human 
campylobacteriosis (LINDMARK et al., 2009). 
Campylobacter spp. is commonly isolated from 
feces of infected cats (ACkE, 2018). C. jejuni was 
first isolated from cats in England in 1977 and in 
the USA in 1980 (KAAKOUSH et al., 2015). 
The poor identification of Campylobacter spp. as 
animal pathogens may result from the simultaneous 
presence of multiple strains or species with various 
pathogenetic characteristics. In routine diagnostic 
laboratories, typing of Campylobacter spp. is 
usually restricted to one colony per stool sample 
(KOENE et al., 2004). More than one subtype of 
Campylobacter spp. within the same species may 
be simultaneously detected as a causative agent 
in human and animal campylobacteriosis cases 
(KAYMAN et al., 2015). 
Some authors reported that Campylobacter 
spp. isolates demonstrated resistances to the 
antibiotics currently used (including macrolides, 
fluoroquinolones and others) (KULKARNI et al., 
2002; SANDBERG et al., 2002; GUPTA et al., 
2004; ENGBERG et al., 2004; ANDRZEJEWSKA 
et al., 2013, SZCZEPANSKA et al., 2017; KUMAR 
et al., 2012). 
In recent years, one of the significant threats 
to public health has been found to be multidrug 
resistant microorganisms (MDR) (MAGIORAKOS 
et al., 2012). MDR reported as a single isolate, 
was resistant to three or more antimicrobial 
classes (ABAY et al., 2012). Bacteria can develop 
multidrug resistance via the gathering of genes 
encoded for resistance to a single drug, or by 
increased expression of genes encoding multiple 
drug delivery pumps in a single cell (NIKAIDO, 
2009). 
In cats, few documents were found on the 
clinical symptoms of campylobacteriosis. In some 
studies, cats infected with Campylobacter spp. 
were clinically healthy, lacking other pathogens 
(FOX, 2012). Moreover, in the studies carried 
out on the pathogenesis of campylobacteriosis, 
motility, adhesion to intestinal epithelial cells, 
invasion to host cells, and cytotoxin production 
are mentioned as important virulence factors of 
Campylobacter spp. (CASABONNE et al., 2016). 
Various genes have been identified with regard to 
the virulence of campylobacters: flaA (Flagellin 
A), CadF (Campylobacter adhesion to fibronectin), 
dnaJ, racR, cj0588 genes are present for adherence 
and colonization; virB11, ciaB (Campylobacter 
invasion antigen B), pldA, iam (invasion-associated 
marker) genes are responsible for invasion; cdtA, 
cdtB, cdtC (cytolethal distending toxin A, B and C) 
genes are accountable for cytotoxin production; and 
wlaN and cgtB genes are related to Guillain-Barre 
syndrome (DATTA et al., 2003; MARTINEZ et al., 
2006; KHOSHBAKHT et al., 2013; QUETZ et al., 
2012; LARSON et al., 2008; KOOLMAN et al., 
2016). 
Due to the limited data about the virulence 
factors, antibiotic resistance and multiple drug 
resistance profiles of Campylobacter spp. in cats, 
we aimed to investigate the virulence genes and 
antibiotic resistance profiles of C. jejuni isolated 
from stool samples of 200 cats brought to Erciyes 
University, Faculty of Veterinary Medicine, 
Training and Research Hospital Clinics. 
materials and methods
Animals. The stool samples taken from different 
breeds and ages (1 month to 9 years) of 200 (116 
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female, 84 male) cats, brought to Erciyes University, 
Faculty of Veterinary Medicine, Training-Research 
and Practice Hospital Clinics, between May 2017 
and April 2018 in for the sake of a year-long study, 
with the permission of the pet owners. The samples 
were divided into two groups on the basis of 
history. One group comprised 22 animals out of the 
200 cats identified as having diarrhea, and 178 cats 
in the other group did not show these symptoms, 
they were non-diarhoeic, and they did not have any 
infectious diseases or antimicrobial treatments (cats 
brought to the clinics for routine examinations and 
vaccination services). In this study, the cats were 
also divided into two groups as “younger than six 
months and older than six months” according to the 
literature (ACKE et al., 2006; 2009a). Regarding 
gender/sex, there were no established criteria, only 
the animal owners' declarations were taken into 
consideration. 
Table 1. Age, gender, non-diarhoeic and diarrhoeic 
status of cats in the study










(n = 125) 8 4 19 94
Female 
(n = 76) 7 3 12 54
Male  
(n = 49) 1 1 7 40
>6 months 
(n = 75) 6 4 8 57
Female 
(n = 40) 4 2 6 28
Male  
(n = 35) 2 2 2 29
Total  
(n = 200) 14 8 27 151
Reference strain. Staphylococcus aureus 
ATCC 25923, Escherichia coli ATCC 25922 and 
Campylobacter jejuni ATCC 700819 were used as 
control strains. 
Isolation, identification and molecular detection 
of virulence genes. Fecal swabs were kept in Cary-
Blair medium (Oxoid, CM0519, UK) no more than 
three hours before culturing. The stool samples were 
inoculated onto modified charcoal cefoperazone 
deoxycholate (mCCD) agar (Oxoid, CM739, UK), 
additionally supplemented with cefoperazone, 
amphotericin B and teicoplanin (CAT supplement, 
Oxoid, SR174, UK), and incubated at 42 °C for 48-
72 h under microaerobic conditions. 
Presumed colonies were confirmed as 
Campylobacter spp. on the basis of cell morphology 
(Gray to white or metallic-highlighted colonies 
growth on a mCCD agar) after the incubation period, 
by phenotypic (colony morphology, Gram staining, 
oxidase test, catalase test and motion test) tests. 
Thereafter, all Campylobacter spp. isolates were 
identified at genus and species level using genus 
specific mPCR assay (WANG et al., 2002). For 
this purpose, template DNA was initially extracted 
using the InstaGene™ Matrix (Bio-Rad, USA) 
kit. Concentrations of the DNA samples (μg/μL) 
were measured by Qubit 3.0 fluorometer (Thermo 
Fisher, USA) and stored at -20 °C until analysis. 
mPCR was carried out in a reaction mixture for 
each sample; 2.5 µL DNA sample, 2.5 µL 10x 
PCR buffer (Thermo Scientific, USA), 20 mM 
MgCl2 (Vivantis, Malaysia), 0.2 mM dNTP mixture 
(Thermo Scientific, USA), 0.5 µM C. jejuni and C. 
lari; 1 µM C. coli and C. fetus, 2 µM C. upsaliensis, 
0.2 µM Campylobacter 23S rRNA primers and 1.25 
U Taq polymerase (Thermo Scientific, USA) were 
prepared by adjusting the final concentration to 25 
µL with sterile distilled water. DNA amplification 
was carried out including an initial denaturation 
step at 95 °C for 6 min, followed by 30 cycles, 
denaturation at 95 °C for 0.5 min, annealing at 
59 °C for 0.5 min, and extension at 72 °C for 0.5 
min, ending with a final extension at 72 °C for 7 
min. in a thermocycler (Arktic™ Thermal Cycler; 
Thermo Fisher, USA). As a result of amplification, 
the PCR products obtained were visualized using 
a UVP gel documentation system (Vilber Lourmat, 
France) after electrophoresis (Thermo EC 330, 
USA) for 90 minutes at 90 V in a 1.5% agarose gel. 
Campylobacter species were identified according 
to the band sizes (Table 2). 
The presence of virulence genes, including iam, 
cadF, cdtA, cdtB, cdtC, flaA, ceuE, and virB11, were 
determined by PCR, as described in earlier studies 
(KRUTKIEWICZ and KLIMUSZKO, 2010; 
CHANSIRIPORNCHAI and SASIPREEYAJAN, 
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2009; DATTA et al., 2003; RIPABELLI et al., 2010) 
with modifications. PCRs for virulence genes were 
carried out in a reaction mixture: 4 µL DNA sample, 
10x PCR buffer with KCl (Thermo Scientific, 
USA), 1.5 mM MgCl2 (Vivantis, Malaysia), 250 
mM dNTP mixture (Thermo Scientific, USA), 1 µM 
each primers and 0.5 U Taq polymerase (Thermo 
Scientific, USA) to adjust the final concentration to 
40 µL with sterile distilled water. The PCR protocol 
included denaturation at 94 °C for 1 min., annealing 
at 52 °C for 1 min. and extension at 72 °C for 1 min. 
followed by 30 cycles, and a final extension at 72 
°C for 5 min. Negative and positive controls were 
used. Further, all the negative samples were tested. 
The amplified products were electrophoresed in a 
1.5% (w/v) TAE agarose gel at 100 V for 1 h. The 
gel was visualized under UV light. The investigated 
primers and expected band size (bp) for mPCR and 
PCRs for virulence genes are summarized in Table 2. 
Table 2. The Oligonucleotide Sequence and Predicted Sizes Used in the PCR
Name Sequence Band size (bp)
Prier-I (CJF) 5’- ACT TCT TTA TTG CTT GCT GC - 3’
323
Primer-II (CJR) 5’- GCC ACA ACA AGT AAA GAA GC - 3’
Primer-I (CCF) 5’- GTAAAACCAAAGCTTATCGTG -3’
126
Primer-II (CCR) 5’- TCCAGCAATGTGTGCAATG -3’
Primer-I (CLF) 5’- TAGAGAGATAGCAAAAGAGA -3’
251
Primer-II (CLR) 5’- TACACATAATAATCCCACCC -3’
Primer-I (CUF) 5’- AATTGAAACTCTTGCTATCC -3’
204
Primer-II (CUR) 5’- TCATACATTTTACCCGAGCT -3’
Primer-I (CFF) 5’- GCAAATATAAATGTAAGCGGAGAG-3’
435
Primer-II (CFR) 5’- TGCAGCGGCCCCACCTAT-3’
23SrRNA-F 5’- TATACCGGTAAGGAGTGCTGGAG-3’
650




cdtAF 5’- GGAAATTGGATTTGGGGCTATACT -3’ 
165 
cdtAR 5’- ATCACAAGGATAATGGACAAT -3’ 
cdtBF 5’- GTTAAAATCCCTGCTATCAACCA -3’ 
495 
cdtBR 5’- GTTGGCACTTGGAATTTGCAAGGC -3’ 
cdtCF 5’- TGGATGATAGCAGGGGATTTTAAC -3’
555
cdtCR 5’- TTGCACATAACCAAAAGGAAG -3’
virB11F 5’- TCTTGTGAGTTGCCTTACCCCTTTT -3’
494 




cadFR1BF 5’- TTGAAGGTAATTTAGATATG-3’ 
400 
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Antibiotic susceptibility testing. The antibiotic 
susceptibilities of the isolates identified as C. jejuni 
were investigated by the disc diffusion method 
and the results were evaluated according to CLSI 
recommendations (CLSI, 2014). The following 
16 antibiotics were used in the study: amoxicillin 
clavulanic acid (AMC, 30 µg), ciprofloxacin (CIP, 
5 µg), trimethoprim sulfamethoxazole (SXT, 25 
µg), enrofloxacin (ENR, 5 µg), clindamycin (DA, 
2 µg), nalidixic acid (NA, 30 µg), streptomycin (S, 
10 µg), tetracycline (TE, 30 µg), doxycycline (DO, 
30 µg), ampicillin (AMP, 10 µg), erythromycin (E, 
15 µg), streptomycin (S, 10 µg), amikacin (AK, 30 
µg), gentamycin (CN, 10 µg), cefotaxime (CTX, 
30 µg), and piperacillin-tazobactam (TZP, 110 µg), 
(Oxoid, UK). Multidrug resistance was evaluated 
as to whether a single isolate was resistant to three 
or more antibacterial classes. 
Enterobacterial repetitive intergenic consensus 
polymerase chain reaction (ERIC-PCR). For 
molecular typing of the isolates, Enterobacterial 
Repetitive Intergenic Consensus Polymerase Chain 
Reaction (ERIC-PCR) was utilized (HOUF et al., 
2002). In the test, ERIC1 and ERIC2 primers were 
used. Briefly, the PCR mixture was 50 μL in total, 
composed of 5 μL 10×PCR buffer, 4 mM MgCl2, 
5 U Taq DNA polymerase, the final concentration 
for the dNTP mixture was 0.2 mM, 25 pmol for 
each primer and 1 μL for template DNA. DNA 
amplification consisted of an initial denaturation at 
94 °C and 5 min, followed by 40 cycles of 94 °C 
for 1 min, 25 °C for1 min and 72 °C for 2 min. The 
amplified products were resolved by electrophoresis 
in a 2% (w/v) TAE agarose gel at 100 V for 1 h. The 
gel was tested and evaluated by visual inspection 
under UV light. 
Statistical analysis. Chi-square tests were used 
for the statistical analysis in the study, in order 
to compare the C. jejuni presence and gender, 
age and diarrhoea status of the cats, using the 
SPSS (Statistical Package for Social Sciences for 
Windows) 23.0 (Armonk, NY: IBM Corp.) program. 
results 
In the study, 41 (20.5%) of 200 stool swab 
samples from cats were positive for the presence of 
Campylobacter spp. In the positive samples, 14 of 
22 (63.6%) were from diarhoeic cats, and 27 of 178 
(15.2%) were non-diarhoeic cats. The difference 
in isolation rate between the diarhoeic cats or non-
diarhoeic cats was statistically significant (P<0.001, 
X2:28.22). Also, in total 71 Campylobacter spp. 
suspicious isolates were recovered from the 41 
positive samples obtained. Phenotypic tests and 
PCR revealed that 65 isolates (20 of them diarrhoeic 
and 45 non-diarhoeic cat isolates) were identified 
as C. jejuni, whereas the six remaining isolates 
were positive at genus but negative at species level. 
The age, gender, non- diarrhea and diarrhea status 
of C. jejuni positive cats are detailed in Table 1. 
The differences in isolation rate in relation to sex 
(P>0.05, P = 0.064, X2:3.432) or age (P>0.05, P = 
0.619, X2:0.247) in diarrhoeic and non-diarhoeic 
cats were not statistically significant. In 19 cat 
samples, more than one subtype of C. jejuni was 
also identified from each sample according to ERIC-
PCR results. It was included that two subtypes of C. 
jejuni isolates were simultaneously found in 14 cat 
samples (three of them were diarrhoeic and 11 of 
them were non-diarhoeic cats) and three subtypes 
of C. jejuni isolates in five positive cat samples 
(two of them were diarrhoeic and three of them 
were non-diarhoeic cats). 
In terms of virulence genes, all the C. jejuni 
isolates harbored at least five virulence genes. All 
isolates were positive for the cadF, cdtC and ceuE 
genes, respectively. The C. jejuni isolates contained 
iam, cadF, cdtA, flaA, ceuE, cdtC, cdtB and virB11, 
at the rate of 19 (29.2%), 65 (100%), 64 (98.4), 54 
(83%), 65 (100%), 65 (100%), 64 (98.4%) and 
22 (33.8%) respectively. Moreover, the cdtA and 
cdtB toxin genes were found in most of the isolates 
analyzed (Table 3). The iam gene was found in 7. 
7% and 21.5% of the diarrhoeic and non-diarhoeic 
cat isolates, respectively. The cadF, ceuE and cdtC 
genes were found in 30.7% and 69.2% of diarrhoeic 
and non-diarhoeic cat isolates, respectively. The 
cdtA and cdtB genes were found in 29.2% and 
69.2% of the diarrhoeic and non-diarhoeic cat 
isolates, respectively. The flaA gene was found 
in 26.1% and 56.9% of the diarrhoeic and non-
diarhoeic cat isolates, respectively. The virB11 
gene was found in 13.8% and 20% of the diarrhoeic 
and non-diarhoeic cat isolates, respectively. 
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In two of the diarrhoeic and four of the 
non-diarhoeic cat isolates, all virulence genes 
were positive. In addition, the combination and 
distribution of virulence genes in diarrhoeic and 
non-diarhoeic cat isolates are presented in Table 4. 
All C. jejuni isolates were susceptible to 
amoxicillin clavulanic acid. The highest resistances 
of the isolates were found as follows: 64 (98.4%), 
63 (96.9%), 62 (95.3%) for ciprofloxacin (CIP), 
trimethoprim sulfamethoxazole (SXT), nalidixic 
acid (NA) antibiotics, respectively (Table 5). In 
64 ciprofloxacin resistant isolates, 20 (30.7%) 
were diarrhoeic cat isolates and 44 (67.6%) were 
non-diarhoeic cat isolates. In 63 trimethoprim 
sulfamethoxazole resistant isolates, 20 (30.7%) 
were diarrhoeic cat isolates and 43 (66.1%) of them 
were non-diarhoeic cat isolates. In 62 nalidixic acid 
resistant isolates, 20 (30.7%) were diarrhoeic cat 
isolates and 42 (64.6%) of them were non-diarhoeic 
cat isolates (Table 5). 
Multiple resistance of isolates was detected 
in the present study. Sixty-one (93.8%) out of 65 
isolates were resistant to three or more antibiotics, 
where the highest resistance levels to antimicrobials 
three and seven were observed in 23.1% and 15.3% 
of the isolates, respectively. Thirteen point eight 
per cent were resistant to antimicrobials five and 
eight, 10.7% to antimicrobials four and six and 
3.1% to antimicrobials nine and ten. In total, 15 
isolates were resistant to three antimicrobials. Four 
of them were diarrhoeic and 11 of them were non-
diarhoeic cat isolates. MDR levels are presented in 
Table 6 in terms of diarrhoeic and non-diarhoeic cat 
isolates. The lowest MDR levels were against 9 and 
10 antibiotics. This was equally distributed to both 
diarrhea and non-diarrhea animals. In addition, the 
highest MDR levels were found to three antibiotics 
in 15 isolates (23.1%), including 4 and 11, from 
diarrhea and non-diarrhea cats, respectively. 
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Table 4. The combination and distribution of Virulence Genes in Diarrhoeic and Non-diarhoeic Cat Isolates
No of virulence genes 
combinations Genes DC NDC
8 ABCDEFGH 2 4
7 BCDEFGH 5 7
7 ABCDEFG 2 8
7 ABCEFGH - 1
6 BCDEFG 7 18
6 BCEFGH 1 1
6 ABCEFG 1 1
5 BCEFG 1 5
5 BDEFH 1 -
A: iam; B: CadF; C: CdtA; D: FlaA; E: CeuE; F: CdtC; G: CdtB; H: VirB11; DC: Number of diarrhoeic cat isolates; NDC: Number 
of non-diarhoeic cat isolates 
Table 5. Antibiotic Resistance Profiles of C. jejuni Isolates
Antibiotics
S (%) I (%) R (%)
N DC NDC N DC NDC N DC NDC
Nalidixic acid (NA) 1 (1. 5) - 1 (1. 5) 2 (3. 1) - 2 (3. 1) 62 (95. 4) 20 (30. 7) 42 (64. 6)
Erythromycin ( E ) 64 (98. 4) 64 (98. 4) - - - - 1 (1. 5) 1 (1. 5)








2 (3. 1) - 2 (3. 1) - - - 63 (96. 9) 20 (30. 7) 43 (66. 1)
Ciprofloxacin (CIP) 1 (1. 5) - 1 (1. 5) - - - 64 (98. 4) 20 (30. 7) 44 (67. 6)
Ampicillin ( AMP) 28 (43. 1) 9 (13. 8) 19 (29. 2) - - - 37 (56. 9) 12 (18. 5) 25 (38. 5)
Enrofloxacin (ENR) 5 (7. 7) - 5 (7. 7) 29 (44. 7) 13 (20) 16 (24. 6) 31 (47. 7) 7 (10. 7) 24 (36. 9)
Clindamycin (DA) 63 (96. 9) 20 (30. 7) 43 (66. 1) 2 (3. 1) - 2 (3. 1) - - -
Tetracycline (TE) 18 (27. 7) 5 (7. 7) 13 (20) 5 (7. 7) 2 (3. 1) 3 (4. 6) 42 (64. 6) 13 (20) 29 (44. 7)
Piperacillin 
tazobactam (TZP) 36 (55. 4) 10 (15. 3) 26 (40) 16 (24. 6) 7 (10. 7) 9 (13. 8) 13 (20) 4 (6. 2) 9 (13. 8)
Cefotaxime (CTX) 43 (66. 1) 14 (21. 5) 29 (44. 7) 11 (16. 9) 4 (6. 2) 7 (10. 7) 11 (16. 9) 3 (4. 6) 8 (12. 3)
Streptomycin (S) 46 (70. 8) 14 (21. 5) 32 (49. 2) 1 (1. 5) 1 (1. 5) 18 (27. 7) 7 (10. 7) 11 (16. 9)
Amikacin (AK) 64 (98. 4) 20 (30. 7) 44 (67. 6) - 1 (1. 5) - -
Gentamicin (CN) 64 (98. 4) 20 (30. 7) 44 (67. 6) - - 1 (1. 5) 1 (1. 5)
Azythromycine 64 (98. 4) 20 (30. 7) 44 (67. 6) - - 1 (1. 5) 1 (1. 5)
S - Susceptible; I -Intermedier; R- Resistant; N: Number of isolates; DC - Diarrhoeic cat isolates; NDC: - Non-diarhoeic cat isolates. 
H. Hızlısoy et al.: Putative virulence genes and antibiotic resistance profiles of Campylobacter jejuni isolated from cats
Vet. arhiv 90 (2), 129-141, 2020136
discussion 
In the present study, the prevalance of 
Campylobacter spp. was 20.5% in the cats examined. 
The frequency of isolation of Campylobacter 
spp. in cats ranges from 8% to 47.8% globally 
(SANDBERG et al., 2002; ENGVALL et al., 2003; 
ACKE et al., 2009a; SALIHU et al., 2010). 
Similar to our study, ABAY et al. (2014), SALIHU 
et al. (2010) and SANDBERG et al. (2002), found 
prevalences of Campylobacter spp. of 26.7%, 18.3% 
and 18% in cats, respectively. However, LAZOU 
et al. (2017), SZCZEPANSKA et al. (2017) and 
ANDRZEJEWSKA et al. (2013) found relatively 
low levels of campylobacters at 15%, 12.1%, 10.5% 
and 9.8% from cats, respectively. The differences in 
the isolation and identification methods (filtration, 
using different media, etc.), sample, regional 
and geographical varieties could be the causes of 
the low level results. In a study by BAkER et al. 
Table 6. Multidrug Resistance Profiles of C. jejuni Isolates
Antibiotic numbers Antibiotic Combinations N DC NDC %
3
NA, SXT, CIP 13 4 9
23. 1
SXT, CIP, AMP 2 - 2
4
NA, SXT, CIP, AMP 2 2
10. 7
NA, SXT, CIP, TE 2 2
NA, SXT, CIP, CTX 1 - 1
NA, SXT, CIP, S 2 2 -
5
NA, SXT, CIP, TE, CTX 2 2 -
13. 8NA, SXT, CIP, ENR, TE 3 1 2
NA, SXT, CIP, AMP, TE 4 2 2
6
NA, SXT, CIP, AMP, ENR, CTX 1 1
10. 7
NA, SXT, CIP, AMP, ENR, TE 2 - 2
NA, DO, SXT, CIP, ENR, TE 2 - 2
NA, SXT, CIP, AMP, TE, S 1 1 -
NA, SXT, CIP, ENR, TE, TZP 1 - 1
7
NA, SXT, CIP, AMP, ENR, TE, S 5 - 5
15. 3
NA, SXT, CIP, AMP, ENR, TE, TZP 3 - 3
NA, E, SXT, CIP, AMP, TE, AZM 1 1 -
NA, DO, SXT, CIP, AMP, ENR, TE 1 - 1
8
NA, DO, SXT, CIP, AMP, ENR, TE, TZP 1 1 -
13. 8
NA, SXT, CIP, AMP, ENR, TE, CTX, S 2 - 2
NA, SXT, CIP, AMP, ENR, TE, TZP, S 1 1 -
NA, DO, SXT, CIP, AMP, ENR, TE, CN 1 1 -
NA, SXT, CIP, AMP, ENR, TE, TZP, CTX 2 - 2
NA, DO, SXT, CIP, AMP, ENR, TE, S 2 1 1
9
NA, DO, SXT, CIP, AMP, ENR, TE, TZP, S 1 1 -
3. 1
NA, SXT, CIP, AMP, ENR, TE, TZP, CTX, S 1 - 1
10 NA, DO, SXT, CIP, AMP, ENR, TE, TZP, CTX, S 2 1 1 3. 1
N - Number of resistance patterns of isolates; DC - number of diarrhoeic cat isolates; NDC - number of non-diarhoeic cat isolates
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(1999) in Southern Australia, the filtration method 
was used for isolation and samples were of different 
origins. LAZOU et al. (2017), conducted a study 
in Greece and used mCCD agar and karmali agar 
for isolation. In ANDRZEJEWSKA et al. (2013) 
samples were collected from Poland and were 
initially inoculated to Preston broth. Later, CCD 
agar was used for isolation of campylobacters. 
Relatively higher results than ours were reported 
by ACKE et al. (2006; 2009b), who reported 
Campylobacter species in 75% and 42.9% from 
cat fecal swab samples. In addition, ACkE et al. 
(2009a) isolated Campylobacter spp. from both 
healthy and diarrhoeic animals at a rate of 45.2% in 
dogs and cats in Ireland. 
In terms of the concurrent presence of C. 
jejuni, in the study, different C. jejuni isolates were 
simultaneously found in 19 (46%) cats, similar to 
SHEN et al. (2001) who reported that 16 (34%) 
of 47 Campylobacter spp. samples were positive 
for more than one species of Campylobacter spp. 
in cat samples. Also, BANG et al. (2001) detected 
that three chickens with two different C. jejuni 
isolates, and one chicken carrying a C. jejuni and 
a C. coli isolate concurrently in Denmark. Also, 
multiple Campylobacter species were found in 
6 (26%) of 23 positive stool samples in dogs 
(KOENE et al., 2004). In another study conducted 
by RICHARDSON et al. (2001), in 7.5% of 
patients, the presence of concomitant infection with 
two different types of C. jejuni was determined by 
molecular typing methods, in humans. According 
to our literature review, this study may be the first 
report of the simultaneous presence of different C. 
jejuni strains in cats in Turkey. Our data clearly 
demonstrated that the synchronous existence of 
different C. jejuni strains is quite frequent in cats. It 
might be of utmost importance for epidemiological 
studies that different strains are found within a 
single species, including the commensal presence, 
for finding the sources of infections, and studies 
on the pathogenicity of Campylobacter spp. in 
cats. Moreover, cases of infection with subtypes of 
one species or more than one species are thought 
to be important in terms of both the antibacterial 
susceptibility and the epidemiology of human 
diseases (KAYMAN et al., 2015). 
In our study, there was a statistically significant 
difference in isolation rate between non-diarhoeic 
or diarrhoeic cats (P<0.05), but no statistically 
significant difference between sex (P>0.05) and 
age status in the cats used as subjects (P>0.05). 
However, previous studies have reported difference 
in relation to age and gender in diarrhoeic and 
healthy animals (BAKER et al., 1999; SANDBERG 
et al., 2002; ENGVALL et al., 2003). 
Since Campylobacter spp. (including C. jejuni, 
C. coli, C. lari and C. upsaliensis) is naturally 
found in the intestinal biota of dogs and cats, cats 
and dogs exhibit a significant hazard for human 
campylobacteriosis (OLSON and SANDSTEDT, 
1987; NEWTON et al., 1988). Campylobacter spp. 
might be a primary or secondary pathogen which is 
related to other predisposing factors, including viral 
infections or opportunistic agents in pets with other 
disorders (ACKE et al., 2009a). 
In the present study, the cadF, cdtC and ceuE 
genes were found in all C. jejuni isolates recovered 
from the cats. Morever, in this study, all isolates 
contained at least five virulence genes. Similar 
results were described by previous studies of 
animals, and they reported that a high ratio of flaA, 
cadF and cdtB genes was found in the analyzed 
isolates from domestic animals (ANDRZEJEWSKA 
et al., 2011; KRUTKIEWICZ and KLIMUSZKO, 
2010; ANDRZEJEWSKA et al., 2013). Also, 
RODRIGUES et al. (2015), among the strains of 
C. jejuni isolates detected in dogs, found that two 
samples (flaA, cadF and ciaB, or flaA, pldA and 
cadF) and two isolates contained the flaA gene or 
cadF and ciaB genes, while two isolates contained 
only one virulence gene (cadF or flaA). BISWAS 
et al. (2011), in C. jejuni isolates from cattle and 
humans, 67% of the isolates contained all of the 
genes except virB11. The cadF gene was found in 
100% of the isolates tested. 
The present study on the antimicrobial 
susceptibility of strains isolated from cats confirmed 
a high level of amoxicillin clavulanic acid. The 
highest level of resistance was to ciprofloxacin 
(CIP), trimethoprim sulfamethoxazole (SXT), 
nalidixic acid (NA), and streptomycin (S). Similar 
results were described in a study conducted by 
ANDRZEJEWSKA et al. (2013), SANDBERG 
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et al. (2002) and SZCZEPANSKA et al. (2017). 
Due to the use of atimicrobial agents in veterinary 
practice, resistant Campylobacter isolates from 
pets and humans have been revealed (GUPTA 
et al., 2004; ENGBERG et al., 2004). Also, a 
study conducted in India on the prevalence of 
antibiotic resistance in dogs showed that isolates 
had a high rate of resistance (97.3%) to cefotaxim, 
chloramphenicol, floxacin, ciprofloxacin, cefaclor, 
nitrofurazone, norfloxacin, gentamicin, amikacin 
and enrofloxacin (KULKARNI et al., 2002). The 
multiple resistance of isolates was detected in 61 
(93.8%) out of 65 isolates that were resistant to 
three or more antibiotics, whereas resistance to three 
and seven antimicrobials was observed in 23.1% 
and 15.3% of the isolates, respectively (Table 3). 
Our results were relatively compatible with those 
of SZCZEPANSKA et al. (2017) and GONI et al. 
(2018), who detected multidrug resistance rates 
of 40% and 50% in Campylobacter spp. isolates, 
respectively. In addition MDR was also reported by 
KUMAR et al. (2012). 
Conclusion
In conclusion, the data obtained in this study 
reveal that the high prevalence of virulence-
associated genes among C. jejuni isolates 
obtained from cats suggests their crucial role in 
the pathogenesis of campylobacteriosis infection 
among cats, and their close contact with humans. 
Moreover, the presence of multidrug resistant 
C. jejuni isolates indicates a potential transmission 
risk from cats to humans. 
Funding sources
This work was not funded by any project. 
conflicts of interest
The authors declare no conflict of interest. 
Acknowledgment
We are grateful to Assoc. Prof. Dr. Nurhan Ertas ONMAZ 
for her technical assistance. We also thank to Assoc. Prof. Dr. 
Aytac AKCAY at Erciyes University, Faculty of Veterinary 
Medicine, Department of Biometri. 
references
ABAY, S., T. KAYMAN, H. HIZLISOY, F. AYDIN (2012): 
In vitro antibacterial susceptibility of Arcobacter butzleri 
isolated from different sources. J. Vet. Med. Sci. 74, 613-
616. 
 DOI: 10.1292/jvms.11-0487 
ABAY, S., F. AYDIN, H. HIZLISOY, V. GUNES (2014): 
Recovery of thermophilic Campylobacter spp. in healthy 
and diarrhoeic pets by culture methods and identification 
of the isolates by multiplex polymerase chain reaction 
(mPCR), Kafkas Univ. Vet. Fak. Derg. 20, 735-741. 
 DOI: 10.9775/kvfd.2014.11010
ACKE, E., P. WHYTE, B. R. JONES, K. MCGILL, J. 
D. COLLINS, S. FANNING (2006): Prevalence of 
thermophilic Campylobacter species in cats and dogs in 
two animal shelters in Ireland. Vet. Rec. 158, 51-54.
 DOI: 10.1136/vr.158.2.51
ACKE, E., K. MCGILL, O. GOLDEN, B. R. JONES, 
S. FANNING, P. WHYTE (2009a): Prevalence of 
thermophilic Campylobacter species in household cats and 
dogs in Ireland. Vet. Rec. 164, 44-47. 
 DOI: 10.1136/vr.164.2.44 
ACKE, E., K. MCGILL, O. GOLDEN, B. R. JONES, S. 
FANNING, P. WHYTE (2009b): A comparison of different 
culture methods for the recovery of Campylobacter species 
from pets. Zoonoses Public Health 56, 490-495. 
 DOI: 10.1111/j.1863-2378.2008.01205.x 
ACKE, E. (2018): Campylobacteriosis in dogs and cats: a 
review, NZ Vet. J. 66, 221-228. 
 DOI: 10.1080/00480169.2018.1475268 
ANDRZEJEWSKA, M,, J. J. KLAWE, B. SZCZEPAŃSKA, 
D. ŚPICA (2011): Occurence of virulence genes among 
Campylobacter jejuni and Campylobacter coli isolates 
from domestic animals and children. Pol. J. Vet. Sci. 14, 
207-211. 
 DOI: 10.2478/v10181-011-0031-x 
ANDRZEJEWSKA, M., B. SZCZEPAŃSKA, J. J. KLAWE, 
D. ŚPICA, M. CHUDZIŃSKA (2013): Prevalence of 
Campylobacter jejuni and Campylobacter coli species in 
cats and dogs from Bydgoszcz (Poland) region. Pol. J. Vet. 
Sci. 16, 115-120. 
 DOI: 10.2478/pjvs-2013-0016 
BAKER, J., M. D. BARTON, J. LANSER (1999): 
Campylobacter species in cats and dogs in South Australia. 
Aust. Vet. J. 77, 662-666. 
 DOI: 10.1111/j.1751-0813.1999.tb13159.x 
BANG, D. D., F. SCHEUTZ, P. AHRENS, K. PEDERSEN, 
J. BLOM, M. MADSEN (2001): Prevalence of cytolethal, 
distending toxin (cdt) genes and CDT production in 
Campylobacter spp. isolated from Danish broilers. J. Med. 
Microbiol. 50, 1087-1094. 
 DOI: 10.1099/0022-1317-50-12-1087 
H. Hızlısoy et al.: Putative virulence genes and antibiotic resistance profiles of Campylobacter jejuni isolated from cats
Vet. arhiv 90 (2), 129-141, 2020 139
BISWAS, D., S. J. HANNON, H. G. G. TOWNSEND, A. 
POTTER, B. J. ALLAN (2011): Genes coding for virulence 
determinants of Campylobacter jejuni in human clinical 
and cattle isolates from Alberta, Canada, and their potential 
role in colonization of poultry. Int Microbiol. 4, 25-32. 
 DOI: 10.2436/20.1501.01.132 
BOJANIĆ, K., A. C. MIDWINTER, J. C. MARSHALL, L. 
E. ROGERS, P. J. BIGGS, E. ACKE (2017): Isolation of 
Campylobacter spp. from client-owned dogs and cats, and 
retail raw meat pet food in the Manawatu. New Zealand. 
Zoonoses Public Health 64, 438-449. 
 DOI: 10.1111/zph.12323 
CASABONNE, C., A. GONZALEZ, V. AQUILI, T. SUBILS, 
C. BALAGUE (2016): Prevalence of seven virulence 
genes of Campylobacter jejuni isolated from Patients with 
diarrhea in Rosario. Argentina. Int. J. Infect. 3(4), e37727 
 DOI: 10.17795/iji-37727 
CHANSIRIPORNCHAI, N., J. SASIPREEYAJAN (2009): 
PCR detection of four virulence-associated genes of 
Campylobacter jejuni isolates from Thai broilers and their 
abilities of adhesion to and invasion of INT-407 cells. J. 
Vet. Med. Sci. 71, 839-844. 
 DOI: 10.1292/jvms.71.839 
CLINICAL AND LABORATORY STANDARDS INSTITUTE 
(2014): Clinical and Laboratory Standards Institute (CLSI) 
Performance standards for antimicrobial susceptibility 
testing; Twenty-Fourth Informational Supplement. CLSI 
document M100-S24. Wayne, PA: Clinical and Laboratory 
Standards Institute. 
DATTA, S., H. NIWA, K. ITOH (2003): Prevalence of 11 
pathogenic genes of Campylobacter jejuni by PCR in 
strains isolated from humans, poultry meat and broiler and 
bovine faeces. J. Med. Microbiol. 52, 345-348. 
 DOI: 10.1099/jmm.0.05056-0 
ENGBERG, J., J. NEIMANN, E. M. NIELSEN, F. M. 
AARESTRUP, F. M. FUSSING, 2004. Quinolone-resistant 
Campylobacter infections in Denmark: risk factors and 
clinical consequences. Emerg. Infect. Dis. 10, 1056-1063. 
 DOI: 10.3201/eid1006.030669 
ENGVALL, E. O., B. BRANDSTROM, L. ANDERSSON, 
V. BAVERUD, G. TROWALD-WIGH, L. ENGLUND 
(2003): Isolation and identification of thermophilic 
Campylobacter species in faecal samples from Swedish 
dogs. Scand. J. Infect. Dis. 35, 713-718. 
 DOI: 10.1080/00365540310014558
FOX, J. G. (2012): Enteric Bacterial Infections, In: Infectious 
Disesases of Dog and Cat. (Greene, C. E., Ed.), 4th ed., 
Saunders Elsevier, St. Louis Missouri USA, p. 371. 
GONI, M. D., A. Y. OSMAN, S. A. AZIZ, Z. ZUNITA, G. K. 
DHALIWAL, M. I. JALO, A. A. BITRUS, M. JAJERE, 
M. A. ABBAS (2018): Antimicrobial resistance of 
Campylobacter spp. and Arcobacter butzleri from pets in 
Malaysia. J. Am. Vet. Med. Assoc. 13, 152-161. 
 DOI: 10.3844/ajavsp.2018.152.161 
GUPTA, A., J. M. NELSON, T. J. BARRETT, R. V. TAUXE, 
S. P. ROSSITER, C. R. FRIEDMAN, K. W. JOYCE, K. E. 
SMITH, T. F JONES, M. A. HAWKINS, B. SHIFERAW, 
J. L. BEEBE, D. J. VUGIA, T. RABATSKY-EHR, J. 
A. BENSON, T. P. ROOT, F. J. ANGULO, NARMS 
WORKING GROUP (2004). Antimicrobial resistance 
among Campylobacter strains, United States, 1997-2001. 
Emerg. Infect. Dis. 10, 1102-1109. 
 DOI: 10.3201/eid1006.030635 
HEREDIA, N., S. GARCIA (2018): Animals as sources of food-
borne pathogens: A review. Animal Nutrition 4, 250-255. 
 DOI: 10.1016/j.aninu.2018.04.006
HOUF, K., L. DE ZUTTER, J. VAN HOOF, P. VANDAMME 
(2002): Assessment of the genetic diversity among 
arcobacters isolated from poultry products by using two 
PCR-based typing methods. Appl. Environ. Microbiol. 68, 
2172-2178. 
 DOI: 10.1128/AEM.68.5.2172-2178.2002 
KAAKOUSH, N. O., N, CASTAN˜O-RODRI´GUEZ, H. M. 
MITCHELL, S. M. MAN (2015): Global Epidemiology of 
Campylobacter Infection. Clin. Microbiol. Rev. 28, 687-
720. 
 DOI: 10.1128/CMR.00006-15 
KAYMAN, T., F. AYDIN, S. ABAY, K. S. DIKER (2015): Co-
infection with Campylobacter jejuni subtypes in patients 
with acute gastroenteritis. Türk Mikrobiyol. Cem. Derg. 
45, 117-121 (in Turkish). 
 DOI: 10.5222/TMCD.2015.117 
KHOSHBAKHT, R., M. TABATABAEI, S. HOSSEINZADEH, 
SS. SHEKARFOROUSH, H. S. ASKI (2013): Distribution 
of nine virulence-associated genes in Campylobacter jejuni 
and C. coli isolated from broiler feces in Shiraz, Southern 
Iran. Foodborne Pathog. Dis. 10, 764-770. 
 DOI: 10.1089/fpd.2013.1489 
KOENE, M. G., D. J. HOUWERS, J. R. DIJKSTRA, B. 
DUIM, J. A. WAGENAAR (2004): Simultaneous presence 
of multiple Campylobacter species in dogs. J. Clin. 
Microbiol. 42, 819-821. 
 DOI: 10.1128/JCM.42.2.819-821.2004 
KOOLMAN, L., P. WHYTE, C. BURGESSA, D. BOLTON 
(2016): Virulence gene expression, adhesion and invasion 
of Campylobacter jejuni exposed to oxidative stress, Int. J. 
Food Microbiol. 220, 33-38. 
 DOI: 10.1016/j.ijfoodmicro 
KRUTKIEWICZ, A., D. KLIMUSZKO (2010): Genotyping 
and PCR detection of potential virulence genes in 
Campylobacter jejuni and Campylobacter coli isolates 
from different sources in Poland. Folia Microbiol. (Praha). 
55, 167-175. 
 DOI: 10.1007/s12223-010-0025-6
KULKARNI, S. P., S. LEVER, J. M. LOGAN, A. LAWSON, 
J. STANLEY, M. S. SHAFI (2002). Detection of 
Campylobacter species: a comparison of culture and 
H. Hızlısoy et al.: Putative virulence genes and antibiotic resistance profiles of Campylobacter jejuni isolated from cats
Vet. arhiv 90 (2), 129-141, 2020140
polymerase chain reaction based methods. J. Clin. Pathol. 
55,749-753. 
 DOI: 10.1136/jcp.55.10.749 
KUMAR, R., A. K., VERMA, A,. KUMAR, M., SRIVASTAVA, 
H. P. LAL (2012): Prevalence of Campylobacter sp. in 
dogs attending veterinary practices at Mathura, India and 
risk indicators associated with shedding. Asian J. Anim. 
Vet. Adv. 7, 754-760. 
 DOI: 10.3923/ajava.2012.754.760 
LARSON, C. L., J. E. CHRISTENSEN, S. A. PACHECO, S. 
A. MINNICH, M. E. KONKEL (2008): Campylobacter 
jejuni Secretes Proteins via the Flagellar Type III Secretion 
System That Contribute to Host Cell Invasion and 
Gastroenteritis. In: Campylobacter. (Nachamkin, I., C. M. 
Szymanski, M. J. Blaser, Eds), ASM Press, Washington 
DC, pp 314-332. 
LAZOU, T., F. FRAGKOU, A. GELASAKIS, C. DOVAS, 
N. SOULTOS, K. ADAMAMA-MORAITOU, E. 
IOSSIFIDOU (2017): Prevalence, antimicrobial resistance 
and risk factors for Campylobacter colonising dogs and 
cats in Greece. BJVM. 20, 244-254. 
 DOI: 10.15547/bjvm.1003 
LINDMARK, H., S. BOQVIST, M. LJUNGSTRÖM, P. 
ÅGREN, B. BJÖRKHOLM, L. ENGSTRAND (2009): 
Risk factors for campylobacteriosis: an epidemiological 
surveillance study of patients and retail poultry. J. Clin. 
Microbiol. 47, 2616-2619. 
 DOI: 10.1128/JCM.00826-09 
MAGIORAKOS, A. P., A. SRINIVASAN, R. B. CAREY, 
Y. CARMELI, M. E. FALAGAS, C. G. GISKE (2012): 
Multidrug-resistant, extensively drug-resistant and 
pandrug-resistant bacteria: an international expert proposal 
for interim standard definitions for acquired resistance. 
Clin. Microbiol. Infect. 18, 268-281. 
 DOI: 10.1111/j.1469-0691.2011.03570.x
MARTINEZ, I., E. MATEO, E. CHURRUCA, C. GIRBAU, 
R. ALONSO, A. FERNÁNDEZ-ASTORGA (2006): 
Detection of cdtA, cdtB, and cdtC genes in Campylobacter 
jejuni by multiplex PCR. Int. J. Med. Microbiol. 296, 45-
48. 
 DOI: 10.1016/j.ijmm.2005.08.003
NEWTON, C. M, D. G. NEWELL, M. WOOD, M. 
BASKERVILLE (1988): Campylobacter infection in a 
closed dog breeding colony. Vet. Rec. 123, 152-154. 
 DOI: 10.1136/vr.123.6.152 
NIKAIDO, H (2009): Multidrug resistance in bacteria. Annu 
Rev. Biochem. 78, 119-146. 
 DOI: 10.1146/annurev.biochem.78.082907.145923 
OLSON, P., K. SANDSTEDT (1987): Campylobacter in the 
dog: a clinical and experimental study. Vet. Rec. 121, 99-
101. 
 DOI: 10.1136/vr.121.5.99 
QUETZ, J. da S., I. F. N. LIMA, A. HAVT, M. M. PRATA, 
P. A. CAVALCANTE, P. H. MEDEIROS, D. A. CID, M. 
L. MORAES, L. C. REY, A. M. SOARES, R. M. MOTA, 
B. H. WEIGL, R. L GUERRANT, A. A. LIMA (2012): 
Campylobacter jejuni infection and virulence associated 
genes in children with moderate to severe diarrhoea 
admitted to emergency rooms in Northeastern Brazil. J. 
Med. Microbiol. 61, 507-513. 
 DOI: 10.1099/jmm.0.040600-0 
RICHARDSON, J. F., J. A. FROST, J. M. KRAMER 
(2001): Coinfection with Campylobacter species: an 
epidemiological problem? J. Appl. Microbiol. 91, 206-211. 
 DOI: 10.1046/j.1365-2672.2001.01377.x 
RIPABELLI, G., M. TAMBURRO, F. MINELLI, A. LEONE, 
M. L. SAMMARCO (2010): Prevalence of virulence-
associated genes and cytolethal distending toxin production 
in Campylobacter spp. isolated in Italy. Comp. Immunol. 
Microbiol. Infect. Dis. 33, 355-364. 
 DOI: 10.1016/j.cimid.2008 
RODRIGUES, C. G, R. T. MELO, B. B. FONSECA, P. A. 
MARTINS, F. A. FERREIRA, M. B. J. ARAUJO, D. 
A. ROSSI (2015): Occurrence and characterization of 
Campylobacter spp. isolates in dogs, cats and children. 
EMBRAPA. 35, 365-370. 
 DOI: 10.1590/S0100-736X2015000400009 
SALIHU, M. D., A. A. MAGAJI, J. U. ABDULKADIR, 
A. KOLAWALE (2010): Survey of thermophilic 
Campylobacter species in cats and dogs in north-western 
Nigeria. Vet. Ital. 46, 425-430. 
SANDBERG, M., B. BERGSJO, M. HOFSHAGEN, 
E. SKJERVE, H. KRUSE (2002): Risk factors for 
Campylobacter infection in Norwegian cats and dogs. 
Prev. Vet. Med. 55, 241-253. 
 DOI: 10.1016/S0167-5877(02)00095-8 
SHEN, Z., Y. FENG, F. E. DEWHIRST, J. G. FOX (2001): 
Coinfection of enteric Helicobacter spp. and Campylobacter 
spp. in cats. J. Clin. Microbiol. 39, 2166-2177. 
 DOI: 10.1128/JCM.39.6.2166-2172.2001 
SPSS (Statistical Package for Social Sciences) for Windows 
Version 23. 0, Armonk, NY, IBM Corp. USA.
SZCZEPANSKA, B., M. ANDRZEJEWSKA, D. SPICA, J. J. 
KLAWE (2017): Prevalence and antimicrobial resistance 
of Campylobacter jejuni and Campylobacter coli isolated 
from children and environmental sources in urban and 
suburban areas. BMC Microbiol. 17, 80. 
 DOI: 10.1186/s12866-017-0991-9 
VANDAMME, P., J. DE LEY (1991): Proposal for a new 
family, Campylobacteraceae. Int. J. Syst Bacteriol. 41, 
451-455. 
 DOI: 10.1099/00207713-41-3-451 
WANG, G., G. C. CLIFFORD, M. T. TRACY (2002): Colony 
multiplex PCR assay for identification and differentiation 
of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and 
C. fetus subsp. fetus. J. Clinical Microbiol. 40, 4744-4747. 
 DOI: 10.1128/JCM.40.12.4744-4747.2002 
H. Hızlısoy et al.: Putative virulence genes and antibiotic resistance profiles of Campylobacter jejuni isolated from cats
Vet. arhiv 90 (2), 129-141, 2020 141
Received: 17 May 2019 
Accepted: 21 October 2019
_____________________________________________________________________________
HızlıSoy, H., İ. KArAcA BeKdıK, Ö. ASlAn, K. S. GümüşSoy, S. HızlıSoy: Geni potencijalne 
virulencije i profili antibiotske rezistencije bakterije campylobacter jejuni izolirane iz mačaka. Vet. arhiv 90, 
129-141, 2020. 
SAžeTAK
Svakodnevni kontakt s mačkama znatan je čimbenik rizika za kampilobakteriozu u ljudi. Glavni je cilj ovoga 
rada bio istražiti gene virulencije i antibiotsku rezistenciju bakterije C. jejuni izolirane iz izmeta mačaka dovedenih 
na Erciyes University, Faculty of Veterinary Medicine, Training and Research Hospital Clinics. Izmet je uzet od 
200 mačaka (116 ženki i 84 mužjaka) različitih pasmina i dobi (1 mjesec do 9 godina), od svibnja 2017. do travnja 
2018. Izolati Campylobacter spp. identificirani su na razini roda i vrste primjenom genski specifičnog multipleks 
PCR-a (mPCR) kojim je ustanovljena prisutnost gena iam, cadF, cdtA, flaA, ceuE, cdtC, cdtB i virB11. Antimikrobna 
rezistencija i otpornost na širok spektar lijekova (MDR) izolata određeni su disk-difuzijskim testom. Primjenom 
Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) otkriveni su genski 
srodnici izolata. U ovom je istraživanju 41 (20,5 %) od 200 uzoraka izmeta bio pozitivan na Campylobacter spp. 
Među pozitivnim uzorcima njih 14 od 22 (63,6 %) potjecalo je od mačaka koje su imale proljev, a 27 od 178 (15,1 
%) uzoraka bilo je od mačaka koje nisu imale proljev. Fenotipski testovi i PCR pokazali su da je 65 izolata (20 od 
njih potjecalo je od mačaka koje su imale proljev i 45 od mačaka koje nisu imale proljev) identificirano kao C. jejuni. 
Razlike u broju izolata s obzirom na spol i dob nisu bile statistički znakovite (P > 0,05). Svi izolati C. jejuni imali su 
barem pet gena virulencije i bili pozitivni na gene cadF, cdtC i ceuE. Gen iam sadržavalo je 19 izolata C. jejuni (29,2 
%), gen cadF 65 izolata (100 %), gen cdtA 64 izolata (98,4 %), gen flaA 54 izolata (83 %), gen ceu E 65 izolata (100 
%), gen cdtC 65 izolata (100 %), gen cdtB 64 izolata (98,4 %) i gen virB11 22 izolata (33,8 %). Geni toksina cdtA 
i cdtB pronađeni su u većini analiziranih izolata. Svi su izolati C. jejuni bili osjetljivi na amoksicilin-klavulansku 
kiselinu. Najveća rezistencija bila je: 64 izolata (98, 4 %) na ciprofloksacin (CIP), 63 izolata (96,9 %) na trimetoprim-
sulfametoksazol (SXT) i 62 izolata (95,3 %) na nalidiksičnu kiselinu (NA). U ovom je istraživanju ustanovljena 
višestruka rezistencija izolata. 61 od 65 izolata (93,8 %) bilo je otporno na tri ili više antibiotika, a najveća je otpornost 
utvrđena na tri antimikrobna lijeka u 23,1 % izolata i na sedam antimikrobnih lijekova u 15,3 % izolata. Istraživanjem 
je ustanovljena otpornost izolata C. jejuni na većinu antibiotika koji se trenutačno primjenjuju te iznimna svojstva 
virulencije u mačaka, koja mogu imati određeni rizik za javno zdravstvo. 
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